deltatrials
Terminated OBSERVATIONAL NCT02431169

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression Following Erlotinib

Sponsor: Washington University School of Medicine

Conditions Carcinoma, Non-Small-Cell-Lung Non-Small Cell Lung Cancer Nonsmall Cell Lung Cancer
Updated 15 times since 2017 Last updated: Jul 15, 2019 Started: Apr 30, 2015 Primary completion: Jun 27, 2019 Completion: Jun 27, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low accrual

Other terminated trials from Washington University School of Medicine

See all terminations from Washington University School of Medicine

Listed as NCT02431169, this observational or N/A phase trial focuses on Carcinoma, Non-Small-Cell-Lung and Non-Small Cell Lung Cancer and remains terminated or withdrawn. Sponsored by Washington University School of Medicine, it has been updated 15 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshot~Mar 2017 – ~Aug 2017 · 5 months · monthly snapshot~Aug 2017 – ~Mar 2018 · 7 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Aug 2019 · 12 months · monthly snapshot~Aug 2019 – ~Nov 2020 · 15 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated

▶ Show 10 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Terminated

  2. Aug 2019 — Nov 2020 [monthly]

    Terminated

    Status: Recruiting → Terminated

  3. Aug 2018 — Aug 2019 [monthly]

    Recruiting

  4. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  5. May 2018 — Jun 2018 [monthly]

    Recruiting

  6. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  7. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  8. Aug 2017 — Mar 2018 [monthly]

    Recruiting NA

  9. Mar 2017 — Aug 2017 [monthly]

    Recruiting NA

  10. Jan 2017 — Mar 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations